Related Experiment Videos
Primary hypercoagulable states in general and vascular surgery
J H Thomas1, G E Pierce, R Delcore
1University of Kansas College of Health Sciences, Kansas City.
Insights
Primary hypercoagulable states, including antithrombin III deficiencies and hypofibrinolytic syndromes, are key causes of thromboembolism in surgical patients. Early diagnosis and anticoagulation therapy are crucial for preventing recurrent events.
Area of Science:
- Medical Science
- Hematology
- Surgical Patient Care
Background:
- Primary hypercoagulable states are increasingly identified as significant contributors to both venous and arterial thromboembolism.
- These conditions pose a considerable risk to patients undergoing surgical procedures.
Purpose of the Study:
- To describe a cohort of 10 patients diagnosed with primary hypercoagulable states over a one-year period.
- To highlight diagnostic indicators and emphasize the efficacy of anticoagulation therapy.
Main Methods:
- Retrospective case series analysis.
- Review of patient medical histories, focusing on family and past history of thromboembolism.
- Identification of thrombotic sites and laboratory evaluation for hypercoagulable abnormalities.
Main Results:
- Ten patients diagnosed with primary hypercoagulable states within one year.
- Antithrombin III deficiencies were the most frequently observed abnormality.
- Three patients presented with hypofibrinolytic syndromes and elevated tissue plasminogen activator inhibitor levels.
Conclusions:
- Accurate diagnosis of hypercoagulable states requires attention to family history, prior thromboembolism, and unusual thrombosis locations.
- Anticoagulation therapy is effective in preventing recurrent thromboembolic events in these patients.
Abstract:
Primary hypercoagulable states are increasingly recognized as causes of venous and arterial thromboembolism in surgical patients. Herein, we describe 10 patients with this syndrome who were diagnosed during a recent 1-year period. A family history and past medical history of thromboembolism and an unusual site of thrombosis are emphasized for accurate diagnosis. Although antithrombin III deficiencies were the most common abnormality found, we describe three patients with hypofibrinolytic syndromes and increased levels of tissue plasminogen activator inhibitor. The effectiveness of anticoagulation therapy in preventing recurrent thromboembolism is stressed.